Wave Life Sciences (WVE) News Today $6.18 +0.18 (+3.00%) As of 01:46 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Research Analysts Issue Forecasts for WVE FY2026 EarningsWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at B. Riley dropped their FY2026 earnings per share estimates for shares of Wave Life Sciences in a research report issued to clients and investors on Thursday, April 10th. B. Riley analyst M. El-Saadi now anticipates thatApril 15 at 1:47 AM | marketbeat.comFY2026 EPS Estimates for Wave Life Sciences Cut by B. RileyApril 15 at 1:35 AM | americanbankingnews.comNorges Bank Invests $1.24 Million in Wave Life Sciences Ltd. (NASDAQ:WVE)Norges Bank acquired a new position in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 100,000 shares of the company's stock, valued at approximately $1,2April 14 at 3:32 AM | marketbeat.comVanguard Group Inc. Raises Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Vanguard Group Inc. increased its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 10.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,182,512 shares of the company's stock after purchasing an additional 294,956 shares during tApril 14 at 3:28 AM | marketbeat.comWhat is Wedbush's Forecast for WVE Q1 Earnings?Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at Wedbush issued their Q1 2025 earnings estimates for shares of Wave Life Sciences in a research report issued to clients and investors on Tuesday, April 8th. Wedbush analyst Y. Zhong anticipates that the company will earnApril 13 at 7:28 AM | marketbeat.comF M Investments LLC Takes Position in Wave Life Sciences Ltd. (NASDAQ:WVE)F M Investments LLC bought a new position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 226,034 shares of the company's stock, valued at approximately $2,796,000. F M IApril 13 at 6:16 AM | marketbeat.comWhat is Wedbush's Estimate for WVE Q1 Earnings?April 13 at 1:25 AM | americanbankingnews.comWave Life Sciences price target lowered to $19 from $22 at B. RileyApril 11, 2025 | markets.businessinsider.comWave Life Sciences (NASDAQ:WVE) Now Covered by Analysts at WedbushWedbush initiated coverage on Wave Life Sciences in a report on Tuesday. They set an "outperform" rating and a $18.00 price objective on the stock.April 10, 2025 | marketbeat.comWedbush Initiates Coverage on Wave Life Sciences (NASDAQ:WVE)April 10, 2025 | americanbankingnews.comWedbush starts RNA-focused standout Wave Life Sciences with an OutperformApril 8, 2025 | markets.businessinsider.comTrexquant Investment LP Has $5.44 Million Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)Trexquant Investment LP raised its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 52.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 439,352 shares of the company's stock after buying an additiApril 7, 2025 | marketbeat.comCinctive Capital Management LP Lowers Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Cinctive Capital Management LP trimmed its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 46.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 191,963 shares of the company's stock after sApril 5, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Trading Down 2.8% - What's Next?Wave Life Sciences (NASDAQ:WVE) Stock Price Down 2.8% - Time to Sell?April 4, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Gap Down - What's Next?Wave Life Sciences (NASDAQ:WVE) Shares Gap Down - Here's What HappenedApril 3, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Nuvation Bio (NUVB)April 2, 2025 | markets.businessinsider.comWhat is Leerink Partnrs' Estimate for WVE Q1 Earnings?Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Wave Life Sciences in a research report issued on Wednesday, March 26th. Leerink Partnrs analyst J. Schwartz expects that the company will post earninMarch 31, 2025 | marketbeat.comLoomis Sayles & Co. L P Takes $20.55 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Loomis Sayles & Co. L P acquired a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 1,660,866 shares of the company's stock, valued at approximately $20,545,000. Loomis Sayles & Co. L P ownMarch 30, 2025 | marketbeat.comArtisan Partners Limited Partnership Trims Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)Artisan Partners Limited Partnership lowered its position in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 2.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,906,790 shares of the company's sMarch 30, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Position Increased by Swiss National BankSwiss National Bank raised its stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 33.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 208,800 shares of the company's stock after buying an additional 52,300 shares durMarch 28, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of "Buy" from AnalystsWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) has earned a consensus recommendation of "Buy" from the ten research firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has giMarch 28, 2025 | marketbeat.comWave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531March 27, 2025 | seekingalpha.comWave Life Sciences unveils Phase II data for DMD therapy, WVE-N531March 27, 2025 | finance.yahoo.comHC Wainwright Reaffirms Buy Rating for Wave Life Sciences (NASDAQ:WVE)HC Wainwright reiterated a "buy" rating and issued a $22.00 target price on shares of Wave Life Sciences in a research note on Wednesday.March 27, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Gap Up - Here's WhyWave Life Sciences (NASDAQ:WVE) Shares Gap Up - Here's WhyMarch 27, 2025 | marketbeat.comWave Life Sciences shares surge on positive DMD trial resultsMarch 27, 2025 | investing.com68,927 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Purchased by Quantbot Technologies LPQuantbot Technologies LP purchased a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 68,927 shares of the company's stock, valued at approximately $853,000. SeveraMarch 27, 2025 | marketbeat.comBRIEF-Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMDMarch 26, 2025 | sg.finance.yahoo.comWave to seek FDA accelerated approval for Duchenne candidate in 2026March 26, 2025 | msn.comAnalysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Wave Life Sciences (WVE)March 26, 2025 | markets.businessinsider.comWave Life Sciences announces data from Phase 2 FORWARD-53 trial of WVE-N531March 26, 2025 | markets.businessinsider.comWave Life Sciences (NASDAQ:WVE) Trading Down 5.3% - Here's What HappenedWave Life Sciences (NASDAQ:WVE) Trading Down 5.3% - Here's What HappenedMarch 26, 2025 | marketbeat.comWave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next YearMarch 26, 2025 | benzinga.comWave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531March 26, 2025 | globenewswire.comWave Life Sciences Ltd. (NASDAQ:WVE) Position Boosted by Emerald Advisers LLCEmerald Advisers LLC boosted its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 9.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,162,369 shares of the company's stock after acquiring an adMarch 24, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Director Christian O. Henry Sells 10,500 SharesWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) Director Christian O. Henry sold 10,500 shares of the stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $9.77, for a total value of $102,585.00. Following the completion of the transaction, the director now directly owns 16,115 shares in the company, valued at approximately $157,443.55. This trade represents a 39.45 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.March 22, 2025 | marketbeat.comInsider Selling: Wave Life Sciences Ltd. (NASDAQ:WVE) Director Sells 10,500 Shares of StockMarch 22, 2025 | insidertrades.comCharles Schwab Investment Management Inc. Grows Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Charles Schwab Investment Management Inc. increased its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 8.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 914,469 shares of the companMarch 22, 2025 | marketbeat.comPrivium Fund Management B.V. Has $1.09 Million Stake in Wave Life Sciences Ltd. (NASDAQ:WVE)Privium Fund Management B.V. lifted its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 80.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 88,000 shares of the company's stocMarch 20, 2025 | marketbeat.comPlatinum Investment Management Ltd. Has $3.86 Million Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)Platinum Investment Management Ltd. lessened its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 32.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 311,992 sMarch 20, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Shares Acquired by Bank of New York Mellon CorpBank of New York Mellon Corp increased its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 21.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 244,973 shares of the company'sMarch 20, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Shares Sold by Primecap Management Co. CAPrimecap Management Co. CA lessened its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 2.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,519,520 shares of the company's stock after selling 61,180March 19, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Has $4.80 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 19.3% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 387,871 shares of the company's stockMarch 17, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Up 13.1% - Still a Buy?Wave Life Sciences (NASDAQ:WVE) Stock Price Up 13.1% - Still a Buy?March 12, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) CEO Paul Bolno Sells 169,025 SharesWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) CEO Paul Bolno sold 169,025 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $9.57, for a total value of $1,617,569.25. Following the completion of the sale, the chief executive officer now owns 338,351 shares of the company's stock, valued at approximately $3,238,019.07. This trade represents a 33.31 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.March 8, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Stock Price Down 6.1% - Here's What HappenedWave Life Sciences (NASDAQ:WVE) Trading Down 6.1% - Here's WhyMarch 8, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for WVE FY2025 Earnings?Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Stock analysts at HC Wainwright lowered their FY2025 earnings estimates for Wave Life Sciences in a report issued on Wednesday, March 5th. HC Wainwright analyst A. Fein now anticipates that the company will earn ($0.87) per share for the year,March 8, 2025 | marketbeat.comPaul Bolno Sells 169,025 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) StockMarch 8, 2025 | insidertrades.comB. Riley Reduces Earnings Estimates for Wave Life SciencesWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Investment analysts at B. Riley cut their Q1 2025 earnings per share estimates for Wave Life Sciences in a research note issued on Wednesday, March 5th. B. Riley analyst M. El-Saadi now anticipates that the company will earn ($0.28) per share fMarch 8, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Rating Increased to Hold at StockNews.comStockNews.com raised Wave Life Sciences from a "sell" rating to a "hold" rating in a report on Saturday.March 8, 2025 | marketbeat.com Remove Ads Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address WVE Media Mentions By Week WVE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WVE News Sentiment▼0.800.80▲Average Medical News Sentiment WVE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WVE Articles This Week▼186▲WVE Articles Average Week Remove Ads Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PTCT News ZLAB News ACLX News RARE News RNA News AKRO News MRUS News OGN News MOR News SWTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WVE) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wave Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wave Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy WVE Stock Free WVE Stock Alerts